403 related articles for article (PubMed ID: 25996046)
41. Bioreducible branched poly(modified nona-arginine) cell-penetrating peptide as a novel gene delivery platform.
Yoo J; Lee D; Gujrati V; Rejinold NS; Lekshmi KM; Uthaman S; Jeong C; Park IK; Jon S; Kim YC
J Control Release; 2017 Jan; 246():142-154. PubMed ID: 27170226
[TBL] [Abstract][Full Text] [Related]
42. Molecular parameters of siRNA--cell penetrating peptide nanocomplexes for efficient cellular delivery.
van Asbeck AH; Beyerle A; McNeill H; Bovee-Geurts PH; Lindberg S; Verdurmen WP; Hällbrink M; Langel U; Heidenreich O; Brock R
ACS Nano; 2013 May; 7(5):3797-807. PubMed ID: 23600610
[TBL] [Abstract][Full Text] [Related]
43. Versatility of cell-penetrating peptides for intracellular delivery of siRNA.
Singh T; Murthy ASN; Yang HJ; Im J
Drug Deliv; 2018 Nov; 25(1):1996-2006. PubMed ID: 30799658
[TBL] [Abstract][Full Text] [Related]
44. Recent in vivo advances in cell-penetrating peptide-assisted drug delivery.
Kurrikoff K; Gestin M; Langel Ü
Expert Opin Drug Deliv; 2016; 13(3):373-87. PubMed ID: 26634750
[TBL] [Abstract][Full Text] [Related]
45. A new amphipathic, amino-acid-pairing (AAP) peptide as siRNA delivery carrier: physicochemical characterization and in vitro uptake.
Jafari M; Xu W; Naahidi S; Chen B; Chen P
J Phys Chem B; 2012 Nov; 116(44):13183-91. PubMed ID: 23077976
[TBL] [Abstract][Full Text] [Related]
46. Attachment of cell-binding ligands to arginine-rich cell-penetrating peptides enables cytosolic translocation of complexed siRNA.
Zeller S; Choi CS; Uchil PD; Ban HS; Siefert A; Fahmy TM; Mothes W; Lee SK; Kumar P
Chem Biol; 2015 Jan; 22(1):50-62. PubMed ID: 25544044
[TBL] [Abstract][Full Text] [Related]
47. Cell Penetrating Peptide Conjugated Chitosan for Enhanced Delivery of Nucleic Acid.
Layek B; Lipp L; Singh J
Int J Mol Sci; 2015 Dec; 16(12):28912-30. PubMed ID: 26690119
[TBL] [Abstract][Full Text] [Related]
48. Harnessing the power of cell-penetrating peptides: activatable carriers for targeting systemic delivery of cancer therapeutics and imaging agents.
MacEwan SR; Chilkoti A
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(1):31-48. PubMed ID: 22977001
[TBL] [Abstract][Full Text] [Related]
49. Intracellular delivery of siRNA by cell-penetrating peptides modified with cationic oligopeptides.
Ishihara T; Goto M; Kodera K; Kanazawa H; Murakami Y; Mizushima Y; Higaki M
Drug Deliv; 2009 Apr; 16(3):153-9. PubMed ID: 19514975
[TBL] [Abstract][Full Text] [Related]
50. Chitosan enhances gene delivery of oligonucleotide complexes with magnetic nanoparticles-cell-penetrating peptide.
Dowaidar M; Nasser Abdelhamid H; Hällbrink M; Langel Ü; Zou X
J Biomater Appl; 2018 Sep; 33(3):392-401. PubMed ID: 30223733
[TBL] [Abstract][Full Text] [Related]
51. Design and evaluation of a stearylated multicomponent peptide-siRNA nanocomplex for efficient cellular siRNA delivery.
Wan Y; Moyle PM; Gn PZ; Toth I
Nanomedicine (Lond); 2017 Feb; 12(4):281-293. PubMed ID: 28093948
[TBL] [Abstract][Full Text] [Related]
52. Magnetic Nanoparticle Assisted Self-assembly of Cell Penetrating Peptides-Oligonucleotides Complexes for Gene Delivery.
Dowaidar M; Abdelhamid HN; Hällbrink M; Freimann K; Kurrikoff K; Zou X; Langel Ü
Sci Rep; 2017 Aug; 7(1):9159. PubMed ID: 28831162
[TBL] [Abstract][Full Text] [Related]
53. Cell-penetrating peptides (CPPs) as a vector for the delivery of siRNAs into cells.
Nakase I; Tanaka G; Futaki S
Mol Biosyst; 2013 May; 9(5):855-61. PubMed ID: 23306408
[TBL] [Abstract][Full Text] [Related]
54. Direct translocation as major cellular uptake for CADY self-assembling peptide-based nanoparticles.
Rydström A; Deshayes S; Konate K; Crombez L; Padari K; Boukhaddaoui H; Aldrian G; Pooga M; Divita G
PLoS One; 2011; 6(10):e25924. PubMed ID: 21998722
[TBL] [Abstract][Full Text] [Related]
55. Development of a novel nanoparticle by dual modification with the pluripotential cell-penetrating peptide PepFect6 for cellular uptake, endosomal escape, and decondensation of an siRNA core complex.
Mitsueda A; Shimatani Y; Ito M; Ohgita T; Yamada A; Hama S; Gräslund A; Lindberg S; Langel Ü; Harashima H; Nakase I; Futaki S; Kogure K
Biopolymers; 2013 Nov; 100(6):698-704. PubMed ID: 23893316
[TBL] [Abstract][Full Text] [Related]
56. Functional peptides for siRNA delivery.
Tai W; Gao X
Adv Drug Deliv Rev; 2017 Feb; 110-111():157-168. PubMed ID: 27530388
[TBL] [Abstract][Full Text] [Related]
57. Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer.
Bolhassani A
Biochim Biophys Acta; 2011 Dec; 1816(2):232-46. PubMed ID: 21840374
[TBL] [Abstract][Full Text] [Related]
58. Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo.
Andaloussi SE; Lehto T; Mäger I; Rosenthal-Aizman K; Oprea II; Simonson OE; Sork H; Ezzat K; Copolovici DM; Kurrikoff K; Viola JR; Zaghloul EM; Sillard R; Johansson HJ; Said Hassane F; Guterstam P; Suhorutšenko J; Moreno PM; Oskolkov N; Hälldin J; Tedebark U; Metspalu A; Lebleu B; Lehtiö J; Smith CI; Langel U
Nucleic Acids Res; 2011 May; 39(9):3972-87. PubMed ID: 21245043
[TBL] [Abstract][Full Text] [Related]
59. Is there a future for cell-penetrating peptides in oligonucleotide delivery?
Lee SH; Castagner B; Leroux JC
Eur J Pharm Biopharm; 2013 Sep; 85(1):5-11. PubMed ID: 23958313
[TBL] [Abstract][Full Text] [Related]
60. Cell-penetrating peptides as versatile vehicles for oligonucleotide delivery.
Margus H; Padari K; Pooga M
Mol Ther; 2012 Mar; 20(3):525-33. PubMed ID: 22233581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
